中缅边境地区恶性疟原虫Pfcrt、Pfmdr和PfK13基因多态性与体外药物敏感性相关性的分析  

Correlation of Pfcrt, Pfmdr and PfK13 gene polymorphisms and in vitro drug susceptibility of Plasmodium falciparum isolates from China-Myanmar border region

作　　者：张苍林[1] 聂仁华[1] 徐丹 吕高伟 王剑 杨亚明[1] 邓艳[1] 刘言 周红宁[1] ZHANG Cang-lin;NIE Ren-hua;XU Dan;LV Gao-wei;WANG Jian;YANG Ya-ming;DENG Yan;LIU Yan;ZHOU Hong-ning(Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research,Yunnan Provincial Center of Malaria Research,Yunnan Provincial Collaborative Innovation Center for Public Health and Disease Prevention and Control,Yunnan Institute of Parasitic Diseases Innovative Team of Key Techniques for Vector Borne Disease Control and Prevention(Developing),Expert Workstation of Professor Jiang Lubing,Yunnan Institute of Parasitic Diseases,Pu'er 665099,China;Midu Center for Disease Control and Prevention,Midu 675600,China;Pu’er Center for Disease Control and Prevention,Pu'er 665099,China;Yunnan Institute of Endemic Disease Control and Prevention,Dali 671000,China)

机构地区：[1]云南省虫媒传染病防控研究重点实验室,云南省疟疾研究中心,云南公共卫生与疾病防控协同创新中心,云南省寄生虫病防治所虫媒传染病防控关键技术省创新团队(培育),普洱市江陆斌专家工作站,云南省寄生虫病防治所,普洱665099 [2]弥渡县疾病预防控制中心,弥渡675600 [3]普洱市疾病预防控制中心,普洱665099 [4]云南省地方病防治所,大理671000

出　　处：《中国寄生虫学与寄生虫病杂志》2020年第5期580-588,共9页Chinese Journal of Parasitology and Parasitic Diseases

基　　金：云南公共卫生与疾病防控协同创新中心项目(No.2014YNPHXT03);国家自然科学基金(No.81160357,No.30960327,No.30660160)。

摘　　要：目的了解中缅边境地区恶性疟原虫对抗疟药物的敏感性及其抗性相关基因多态性之间的关系,为当地制定合理的疟疾药物策略提供依据。方法 2009年在缅甸拉咱市农日班诊所设立调查点,选取镜检为单一感染恶性疟原虫,2周内未用过抗疟药、磺胺和四环素类药物的现症患者为调查对象,给药前采集患者全血或滤纸血滴,用于体外药物敏感性测定和基因检测。运用Rieckmann体外微量测定法对恶性疟原虫进行体外青蒿素、氯喹、哌喹和咯萘啶敏感性检测。提取全血或滤纸血滴DNA,进行恶性疟原虫氯喹抗性转运基因(Pfcrt)、多药抗性基因(Pfmdr)和Kelch基因(PfK13)抗性相关基因检测。应用SPSS 23.0软件Spearman秩相关系数检验分析恶性疟原虫药物抗性与其携带基因之间的关系。结果共收集镜检为单一感染恶性疟原虫患者血样63份,体外药物敏感测定51例,成功测定42例,占82.4%。恶性疟原虫对氯喹的平均抑制浓度、半数抑制量(ID50)和抗性率较高,分别为880 nmol/L、 320.5 nmol/L和95.2%;对咯萘啶平均抑制浓度、青蒿素ID50和哌喹抗性率较低,分别为410 nmol/L、 84.8 nmol/L和7.1%。在对氯喹有抗性的40份血样中,对咯萘啶、青蒿素和哌喹的交叉抗性率分别为52.5%(21/40)、 37.5%(15/40)和7.5%(3/40);对哌喹有抗性的3份血样中,对氯喹、青蒿素和咯萘啶的交叉抗性率均为3/3。存在交叉抗性的血样从高到低分别为:氯喹与咯萘啶21份,氯喹与青蒿素15份,青蒿素与咯萘啶13份,哌喹与氯喹、青蒿素和咯萘啶均为3份。Spearman秩相关系数检验分析显示,青蒿素与哌喹和咯萘啶的抗性之间均存在相关性(r=0.354、 0.446, P <0.05)。基因检测结果显示,Pfcrt基因成功测序37份,均为74~76位点C72V73I74E75T76三重突变基因型,突变率为100%(37/37)。Pfmdr基因在第86和1246位点分别成功测序47和49份血样,突变率分别为N86Y (2.1%, 1/47)和D1246Y (100%, 49/49Objective To investigate correlation between the susceptibility to antimalarials and the polymorphisms of drug resistance genes of Plasmodium falciparum isolates from China-Myanmar border region,to provide basis for formulating rational strategy for using antimalarial drugs in the local areas.Methods In 2009,an investigation site was set up at the Nongriban Clinic in Lazan City,Myanmar,and the participant patients were selected based on the inclusion criteria:single infection of P.falciparum diagnosed by microscopy;and no chemotherapy history with antimalarials,sulfonamides,or tetracyclines within the past 2 weeks.For in vitro drug sensitivity test and genetic analysis,whole blood or filter paper blood samples were collected from the patients prior to drug treatment.The Rieckmann in vitro microassay method was used to assess the susceptibility of P.falciparum parasites to artemisinin,chloroquine,piperquine and pyronidine.Blood DNA was prepared to test examine the polymorphisms of chloroquine resistant transporter gene(Pfcrt),multiple-drug resistance(Pfmdr)and Kelch gene(PfK13).The associations between the susceptibility to antimalarial drugs and gene polymorphisms were analyzed with Spearman rank correlation coefficient test by SPSS 23.0 software.Results A total of 63 patients with single infection of P.falciparum examined by microscopy were included in this study,of them 51 samples underwent in vitro drug susceptibility test,with 42 samples were completed successfully,accounting for 82.4%(42/51).In the in vitro assay,P.falciparum showed higher mean inhibitory concentration,higher 50%inhibitory dose(ID50)and higher resistance rate to chloroquine,which were 880 nmol/L,320.5 nmol/L and 95.2%,respectively;and showed lower mean inhibitory concentration to pyronaridine(410 nmol/L),lower ID50 to artemisinin(84.8 nmol/L)and lower resistant rate to piperaquine(7.1%).Of the 40 blood samples resistant to chloroquine,the cross resistance rate to pyronaridine was52.5%(21/40),to artemisinin 37.5%(15/40)and to piperaquine 7.5%

关 键 词：恶性疟原虫 药物敏感性 体外微量测定 抗性基因 缅甸拉咱市 

分 类 号：R382.312[医药卫生—医学寄生虫学]